AR014119A1 - Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis - Google Patents

Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis

Info

Publication number
AR014119A1
AR014119A1 ARP980105823A ARP980105823A AR014119A1 AR 014119 A1 AR014119 A1 AR 014119A1 AR P980105823 A ARP980105823 A AR P980105823A AR P980105823 A ARP980105823 A AR P980105823A AR 014119 A1 AR014119 A1 AR 014119A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
complications associated
compositions intended
laterosclerosis
cetolids
Prior art date
Application number
ARP980105823A
Other languages
English (en)
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of AR014119A1 publication Critical patent/AR014119A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Se describe la utilizacion de cetolidas para la preparacion de composiciones farmacéuticas destinadas a prevenir las complicacionestromboticas arteriales asociadas a la aterosclerosis. Las cetolidas responden a la formula (I) en la cualR representa un radical (CH2)mOn(X)YAr en la cual mrepresenta el numero 0 o 1, n representa el numero 0 o 1, X representa un radical (NH)a, CH2 o SO2, representando al numero 0 o 1, Y representa unradical (CH2)b-(CH=CH)c-(CH2)d con c= 0 o 1, b+ c + d < o = que 8, Z representa un átomo de hidrogeno o de halogeno, y Ar representa un radicalarilo o heteroarilo eventualmente sustituido.
ARP980105823A 1997-11-17 1998-11-17 Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis AR014119A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9714358A FR2771008B1 (fr) 1997-11-17 1997-11-17 Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose

Publications (1)

Publication Number Publication Date
AR014119A1 true AR014119A1 (es) 2001-02-07

Family

ID=9513423

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980105823A AR014119A1 (es) 1997-11-17 1998-11-17 Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis

Country Status (35)

Country Link
US (1) US20080139489A1 (es)
EP (1) EP1030673B1 (es)
JP (1) JP4550273B2 (es)
KR (1) KR20010032130A (es)
CN (1) CN1286633A (es)
AP (1) AP1196A (es)
AR (1) AR014119A1 (es)
AT (1) ATE271875T1 (es)
AU (1) AU744419B2 (es)
BG (1) BG104427A (es)
BR (1) BR9814199A (es)
CA (1) CA2312021C (es)
DE (1) DE69825308T2 (es)
DZ (1) DZ2654A1 (es)
EA (1) EA003322B1 (es)
EE (1) EE04095B1 (es)
ES (1) ES2224446T3 (es)
FR (1) FR2771008B1 (es)
GE (1) GEP20032968B (es)
HR (1) HRP20000314A2 (es)
HU (1) HUP0004507A3 (es)
ID (1) ID24940A (es)
IL (1) IL136149A0 (es)
MA (1) MA26566A1 (es)
NO (1) NO20002435L (es)
NZ (1) NZ504305A (es)
OA (1) OA11411A (es)
PL (1) PL340373A1 (es)
SK (1) SK7042000A3 (es)
TN (1) TNSN98206A1 (es)
TR (1) TR200001384T2 (es)
TW (1) TW472061B (es)
WO (1) WO1999025365A1 (es)
YU (1) YU29600A (es)
ZA (1) ZA9810357B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
EP1137654A1 (en) * 1998-12-10 2001-10-04 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
EP1147121B1 (en) * 1999-01-27 2003-12-17 Pfizer Products Inc. Ketolide antibiotics
EP1114826A3 (en) * 1999-12-29 2001-10-31 Pfizer Products Inc. Novel antibacterial and prokinetic macrolides
JP2003529593A (ja) 2000-04-04 2003-10-07 スミスクライン ビーチャム パブリック リミテッド カンパニー 抗菌剤として用いるための２−ヒドロキシムチリンカルバメート誘導体
JP2004323414A (ja) * 2003-04-24 2004-11-18 Japan Science & Technology Agency １４員環マクロライド化合物を利用した、血管平滑筋の増殖に起因する疾患治療剤
GB0402578D0 (en) * 2004-02-05 2004-03-10 Cambridge Theranostics Ltd Methods of treatment of atherosclerosis
JP6042334B2 (ja) * 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5424187A (en) * 1991-06-14 1995-06-13 Board Of Regents Of The University Of Washington Method of screening for arterial chlamydial granuloma
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6271255B1 (en) * 1996-07-05 2001-08-07 Biotica Technology Limited Erythromycins and process for their preparation
GB9621771D0 (en) * 1996-10-18 1996-12-11 St George S Enterprises Ltd Method of treatment of heart disease
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics

Also Published As

Publication number Publication date
AU744419B2 (en) 2002-02-21
GEP20032968B (en) 2003-05-27
AP2000001825A0 (en) 2000-06-30
IL136149A0 (en) 2001-05-20
SK7042000A3 (en) 2000-12-11
ES2224446T3 (es) 2005-03-01
US20080139489A1 (en) 2008-06-12
TW472061B (en) 2002-01-11
WO1999025365A1 (fr) 1999-05-27
AU1242599A (en) 1999-06-07
CA2312021A1 (fr) 1999-05-27
HRP20000314A2 (en) 2001-02-28
NO20002435D0 (no) 2000-05-11
ZA9810357B (en) 1999-11-12
EE04095B1 (et) 2003-08-15
CN1286633A (zh) 2001-03-07
MA26566A1 (fr) 2004-12-20
OA11411A (fr) 2004-04-20
KR20010032130A (ko) 2001-04-16
TR200001384T2 (tr) 2001-06-21
FR2771008B1 (fr) 2000-04-28
YU29600A (sh) 2003-02-28
JP2001523644A (ja) 2001-11-27
EA200000531A1 (ru) 2000-10-30
CA2312021C (fr) 2008-08-26
ID24940A (id) 2000-08-31
EP1030673B1 (fr) 2004-07-28
EP1030673A1 (fr) 2000-08-30
BR9814199A (pt) 2000-09-26
DZ2654A1 (fr) 2003-03-22
FR2771008A1 (fr) 1999-05-21
PL340373A1 (en) 2001-01-29
NZ504305A (en) 2002-11-26
JP4550273B2 (ja) 2010-09-22
DE69825308D1 (de) 2004-09-02
NO20002435L (no) 2000-07-07
AP1196A (en) 2003-08-18
HUP0004507A1 (hu) 2001-05-28
HUP0004507A3 (en) 2001-12-28
DE69825308T2 (de) 2005-08-04
BG104427A (en) 2001-02-28
EA003322B1 (ru) 2003-04-24
TNSN98206A1 (fr) 2005-03-15
ATE271875T1 (de) 2004-08-15
EE200000244A (et) 2001-06-15

Similar Documents

Publication Publication Date Title
DK0790771T3 (da) Kombinationer af phenylsulfonylurinstof-herbicider og safeners
EE9900217A (et) Sulfiinhappe derivaadid, nende valmistamine ja kasutamine
DK472587A (da) Polysaccharidkompositioner
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
BR9803883A (pt) Derivado de amida.
DK330786D0 (da) Anvendelse af n-(4-phenoxy-2,6-diisopropyl-phenyl)-n&#39;-tert-butyl-thiourinstof til bekaempelse af hvide fluer
IT1221734B (it) Ursodesossicolico solfato acido sale sodico
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
FI834872A0 (fi) Substituerade 4-aminoetylen-kromaner och -kromener, foerfaranden foer deras framstaellning och deraanvaendning som laekemedel
ES2104090T3 (es) Nuevas 3&#39;,5&#39;-di-t-butil-4&#39;-hidroxi-flavonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69625354D1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
BR9811914A (pt) Composição sólida para reduzir a erosão dos dentes
AR014119A1 (es) Utilizacion de cetolidas para la fabricacion de composiciones farmaceuticas destinadas a prevenir complicaciones tromboticas arteriales asociadas a laaterosclerosis
ES2086436T3 (es) Nuevos eteres y tioeteres de piperidilo inhibidores de la biosintesis de colesterol.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
DE69940551D1 (de) Mercaptane und disulfide
MX9300584A (es) Mezcla de oligosacaridos sulfatados, procedimiento para su preparacion y composicion farmaceutica que la contiene.
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
BR9904951A (pt) Compostos cìclicos tendo uma cadeia cicloalquileno, processo para sua preparação e composições farmacêuticas contendo os mesmos
TR199800210T2 (xx) Didepsipeptid temelli endoparazitisid kompozisyonlar, yeni didepsipeptidler ve bunlar�n �retimi i�in i�lemler.
DE3667914D1 (de) Entzuendungshemmende zusammensetzungen und verfahren.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ES2074264T3 (es) Esteres de aminoacidos de la hidroquinona, su procedimiento de preparacion y composiciones farmaceuticas o cosmeticas que los contienen.
ATE30676T1 (de) Antithrombotische und/oder antihypertensive zusammensetzungen.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal